Copyright © 1999 by the European Society of Cardiology.
Editorial
Editorials
Lipids and coronary restenosis: an elusive link
1999, 1999
References
- Mintz GS, Popma JJ, Pichard AD. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:3543
[Abstract/Free Full Text] - Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science. 1976;193:10941100
[Abstract/Free Full Text] - Minnick CR, Stemerman MB, Insull W. Role of endothelium and hypercholesterolemia in intimal thickening and lipid accumulation. Am J Pathol. 1979;95:135158
- Jørgensen B, Simonsen S, Endresen K, Forfang K, Egeland T, Høstmark AT, Thaulow E. Luminal loss and restenosis after coronary angioplasty; the role of lipoproteins and lipids. Eur Heart J. 1999;20:14071414
[Abstract/Free Full Text] - Austin GE, Lynn M, Hollman J. Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty. Arch Pathol Lab Med. 1987;111:11581162[Web of Science][Medline]
- Austin GE, Hollman J, Lynn MJ, Meier B. Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis. Cleve Clin J Med. 1989;56:509514[Web of Science][Medline]
- Arora RR, Konrad K, Badhwar K, Hollman J. Restenosis after transluminal coronary angioplasty: a risk factor analysis. Cathet Cardiovasc Diagn. 1990;19:1722[Web of Science][Medline]
- Johansson SR, Wiklund O, Karlsson T, Hjalmarson A, Emanuelsson H. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty. Eur Heart J. 1991;12:10201028[Web of Science][Medline]
- Foley JB, Younger K, Foley D. Lipids and fatty acids and their relationship to restenosis. Cathet Cardiovasc Diagn. 1992;25:2530[Web of Science][Medline]
- Hearn JA, Donohue BC, Ba'albaki H. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1992;69:736739[CrossRef][Web of Science][Medline]
- Violaris AG, Melkert R, Serruys PW. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions. Circulation. 1994;90:22672279
[Abstract/Free Full Text] - Roth A, Eshchar Y, Keren G. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group. Am J Cardiol. 1994;73:11541158[CrossRef][Web of Science][Medline]
- Cooke T, Sheahan R, Foley D. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 1994;89:15931598
[Abstract/Free Full Text] - Yamamoto H, Imazu M, Yamabe T, Ueda H, Hattori Y, Yamakido M. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a). Am Heart J. 1995;130:11681173[CrossRef][Web of Science][Medline]
- Dzavik V, Teo KK, Yokoyama S. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240mg/dl and triglycerides 350mg/dl. Am J Cardiol. 1995;75:936938[CrossRef][Web of Science][Medline]
- Horie H, Takahashi M, Izumi M. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Circulation. 1997;96:166173
- Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science. 1993;260:16551658
[Abstract/Free Full Text] - Wehinger A, Kastrati A, Elezi S. Lipoprotein(a) and coronary thrombosis and restenosis after stent placement. J Am Coll Cardiol. 1999;33:10051012
[Abstract/Free Full Text] - Corsini A, Mazzotti M, Raiteri M. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis. 1993;101:117125[CrossRef][Web of Science][Medline]
- Soma MR, Donetti E, Parolini C. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb. 1993;13:571578
[Abstract/Free Full Text] - Gellman J, Ezekowitz MD, Sarembock IJ. Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit. J Am Coll Cardiol. 1991;17:251259[Abstract]
- Sahni R, Maniet AR, Voci G, Banka VS. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J. 1991;121:16001608[CrossRef][Web of Science][Medline]
- Kleemann A, Eckert S, von Eckardstein A. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA; the Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT). Eur Heart J. 1999;20:13931406
[Abstract/Free Full Text] - Weintraub WS, Boccuzzi SJ, Klein JL. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med. 1994;331:13311337
[Abstract/Free Full Text] - Bertrand ME, McFadden EP, Fruchart JC. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty. J Am Coll Cardiol. 1997;30:863869[Abstract]
- Serruys PW, Foley DP, Jackson G. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J. 1999;20:5869
[Abstract/Free Full Text] - Kimura T, Kaburagi S, Tamura T. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 1997;96:475483
[Abstract/Free Full Text] - Vos J, de Feyter PJ, Simoons ML, Tijssen JG, Deckers JW. Retardation and arrest of progression or regression of coronary artery disease: a review. Prog Cardiovasc Dis. 1993;35:435454[CrossRef][Web of Science][Medline]
- Lancet. 1994;344:13831389[CrossRef][Web of Science][Medline]
- Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:10011009
[Abstract/Free Full Text] - Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:13011307
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||